Nom du produit:3-(2-cinnamylidenehydrazinyl)-1H-quinoxalin-2-one
IUPAC Name:3-{2-[(2E)-3-phenylprop-2-en-1-ylidene]hydrazin-1-yl}-1,2-dihydroquinoxalin-2-one
- CAS:338419-76-4
- Formule moléculaire:C17H14N4O
- Pureté:95%+
- Numéro de catalogue:CM706776
- Poids moléculaire:290.33
Unité d'emballage |
Stock disponible |
Prix($) |
Quantité |
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:338419-76-4
- Formule moléculaire:C17H14N4O
- Point de fusion:-
- Code SMILES:O=C1NC2=CC=CC=C2N=C1NN=C\C=C\C1=CC=CC=C1
- Densité:
- Numéro de catalogue:CM706776
- Poids moléculaire:290.33
- Point d'ébullition:
- N° Mdl:MFCD00139696
- Stockage:
Category Infos
- Quinoxalines
- Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.